P53+/mdm2- Atypical Lipomatous Tumor/well-differentiated Liposarcoma in Young Children: an Early Expression of Li-Fraumeni Syndrome
Overview
Authors
Affiliations
The spectrum of lipomatous tumors differs in the adult and pediatric populations, with liposarcoma being rare in children. Nearly 10% of individuals with Li-Fraumeni syndrome develop sarcomas in the first 2 decades of life; however, the frequency of sarcoma types and subtypes in this syndrome is unknown. Two atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLS) were identified in the pathology files of our institution in young children from "classical" Li-Fraumeni and Li-Fraumeni variant kindreds with a known germline TP53 mutation (Y220C) in one of the families. The patients were 5 and 6 years of age and the ALT/WDLSs were the first expression of the syndrome. The tumors had a high degree of cellular atypia and differed from sporadic ALT/WDLS by strong nuclear immunoreactivity for p53 and absent mdm2 expression. This is the first report of 2 ALT/WDLSs presenting in children before 10 years of age, both in association with Li-Fraumeni syndrome/variant. ALT/WDLS in a young child should raise the possibility of a cancer predisposition syndrome and, in this setting, the p53(+)/mdm2(-) immunophenotype might be characteristic. Recognition of this lesion and its association is important for early diagnosis and subsequent tumor surveillance in the proband and affected family members.
Case report: Atypical lipomatous tumor of the thigh in a four-year-old girl.
Ogawa I, Hakozaki M, Kaneuchi Y, Suzuki T, Nikaido T, Yamada S Front Oncol. 2024; 14:1401861.
PMID: 39109289 PMC: 11300325. DOI: 10.3389/fonc.2024.1401861.
Watanabe H, Fujishima F, Motoi T, Aoyama Y, Niihori T, Takahashi M Diagn Pathol. 2022; 17(1):93.
PMID: 36514176 PMC: 9746193. DOI: 10.1186/s13000-022-01264-x.
Ameloot E, Cordier F, Van Dorpe J, Creytens D J Clin Med. 2022; 11(7).
PMID: 35407546 PMC: 8999862. DOI: 10.3390/jcm11071938.
Hammer P, Kunder C, Howitt B, Charville G Histopathology. 2021; 80(4):656-664.
PMID: 34725851 PMC: 8860877. DOI: 10.1111/his.14593.
MDM2 Amplified Sarcomas: A Literature Review.
Sciot R Diagnostics (Basel). 2021; 11(3).
PMID: 33799733 PMC: 8001728. DOI: 10.3390/diagnostics11030496.